WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$3.65
+2.00%Margins
Gross margin
96.8%
EBITDA margin
-289.7%
EBIT margin
-320.9%
Net margin
-296.9%
FCF margin
-284.1%
-52.4%
Return on equity
-41.4%
Return on assets
-51.1%
Return on invested capital
0.13x
Asset turnover
-$200.2M
Cash from operations
$2.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026